The term 'super-enhancer' has been used to describe groups of putative enhancers in close genomic proximity with unusually high levels of Mediator binding, as measured by chromatin immunoprecipitation ...

Enhancer malfunction is a key process that drives the aberrant regulation of oncogenes in cancer. Enhancer variants contribute more than any other known mechanism to heritable cancer predisposition.